Contec Historical Income Statement

300869 Stock

15.48 0.19 1.24%

Historical analysis of Contec Medical income statement accounts such as Interest Expense of 47.4 M, Selling General Administrative of 10 M or Selling And Marketing Expenses of 63.4 M can show how well Contec Medical Systems performed in making a profits. Evaluating Contec Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Contec Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Contec Medical Systems latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Contec Medical Systems is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Contec Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Contec Income Statement Analysis

Contec Medical Systems Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Contec Medical shareholders. The income statement also shows Contec investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Contec Medical Income Statement Chart

At present, Contec Medical's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Operating Income is expected to grow to about 194 M, whereas Depreciation And Amortization is forecasted to decline to about 15.9 M.

Selling General Administrative Selling And Marketing Expenses Gross Profit

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Contec Medical Systems minus its cost of goods sold. It is profit before Contec Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Contec Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Contec Medical Systems current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Contec Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Gross Profit	446.0M	338.1M	404.7M	317.7M
Total Revenue	908.7M	712.1M	734.0M	609.6M

Gross Profit Total Revenue

Contec Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Tax Provision	Net Interest Income	Interest Income	Net Income From Continuing Ops	Reconciled Depreciation
Depreciation And Amortization		0.69	0.7	0.97	0.55	0.5	0.79	0.26	0.23	0.95	0.26	0.6	0.85	0.33	0.55	0.34	0.27	0.17	0.68	0.86	0.25	0.89
Interest Expense	0.69		0.6	0.67	0.27	0.26	0.45	0.05	0.03	0.67	0.05	0.28	0.93	0.11	0.9	0.12	0.06	0.06	0.43	0.64	0.13	0.85
Selling General Administrative	0.7	0.6		0.76	0.67	0.67	0.76	0.5	0.48	0.79	0.5	0.66	0.64	0.56	0.41	0.56	0.51	0.47	0.62	0.76	0.53	0.72
Selling And Marketing Expenses	0.97	0.67	0.76		0.63	0.57	0.85	0.35	0.32	0.97	0.35	0.68	0.84	0.41	0.47	0.42	0.35	0.24	0.75	0.91	0.33	0.87
Total Revenue	0.55	0.27	0.67	0.63		0.99	0.93	0.94	0.93	0.62	0.94	0.99	0.46	0.96	0.1	0.97	0.94	0.89	0.72	0.67	0.93	0.38
Gross Profit	0.5	0.26	0.67	0.57	0.99		0.89	0.95	0.95	0.56	0.95	0.95	0.41	0.98	0.11	0.98	0.96	0.92	0.64	0.61	0.95	0.35
Other Operating Expenses	0.79	0.45	0.76	0.85	0.93	0.89		0.78	0.76	0.85	0.78	0.96	0.67	0.82	0.24	0.82	0.77	0.69	0.86	0.87	0.75	0.62
Operating Income	0.26	0.05	0.5	0.35	0.94	0.95	0.78		1.0	0.36	1.0	0.91	0.21	0.99	-0.11	0.99	0.99	0.98	0.59	0.46	0.99	0.11
Ebit	0.23	0.03	0.48	0.32	0.93	0.95	0.76	1.0		0.33	1.0	0.9	0.18	0.99	-0.11	0.99	0.99	0.98	0.57	0.44	0.98	0.09
Research Development	0.95	0.67	0.79	0.97	0.62	0.56	0.85	0.36	0.33		0.35	0.68	0.83	0.41	0.43	0.43	0.35	0.25	0.83	0.96	0.35	0.89
Ebitda	0.26	0.05	0.5	0.35	0.94	0.95	0.78	1.0	1.0	0.35		0.91	0.2	0.99	-0.1	0.99	0.99	0.98	0.59	0.46	0.98	0.11
Cost Of Revenue	0.6	0.28	0.66	0.68	0.99	0.95	0.96	0.91	0.9	0.68	0.91		0.51	0.93	0.08	0.93	0.9	0.83	0.8	0.74	0.87	0.41
Total Operating Expenses	0.85	0.93	0.64	0.84	0.46	0.41	0.67	0.21	0.18	0.83	0.2	0.51		0.27	0.79	0.27	0.21	0.15	0.66	0.8	0.24	0.86
Income Before Tax	0.33	0.11	0.56	0.41	0.96	0.98	0.82	0.99	0.99	0.41	0.99	0.93	0.27		-0.03	1.0	1.0	0.98	0.6	0.5	0.99	0.19
Total Other Income Expense Net	0.55	0.9	0.41	0.47	0.1	0.11	0.24	-0.11	-0.11	0.43	-0.1	0.08	0.79	-0.03		-0.02	-0.05	-0.04	0.11	0.35	0.0	0.7
Net Income	0.34	0.12	0.56	0.42	0.97	0.98	0.82	0.99	0.99	0.43	0.99	0.93	0.27	1.0	-0.02		1.0	0.97	0.61	0.51	0.99	0.2
Income Tax Expense	0.27	0.06	0.51	0.35	0.94	0.96	0.77	0.99	0.99	0.35	0.99	0.9	0.21	1.0	-0.05	1.0		0.99	0.54	0.44	0.99	0.13
Tax Provision	0.17	0.06	0.47	0.24	0.89	0.92	0.69	0.98	0.98	0.25	0.98	0.83	0.15	0.98	-0.04	0.97	0.99		0.47	0.36	0.99	0.08
Net Interest Income	0.68	0.43	0.62	0.75	0.72	0.64	0.86	0.59	0.57	0.83	0.59	0.8	0.66	0.6	0.11	0.61	0.54	0.47		0.93	0.55	0.59
Interest Income	0.86	0.64	0.76	0.91	0.67	0.61	0.87	0.46	0.44	0.96	0.46	0.74	0.8	0.5	0.35	0.51	0.44	0.36	0.93		0.45	0.83
Net Income From Continuing Ops	0.25	0.13	0.53	0.33	0.93	0.95	0.75	0.99	0.98	0.35	0.98	0.87	0.24	0.99	0.0	0.99	0.99	0.99	0.55	0.45		0.16
Reconciled Depreciation	0.89	0.85	0.72	0.87	0.38	0.35	0.62	0.11	0.09	0.89	0.11	0.41	0.86	0.19	0.7	0.2	0.13	0.08	0.59	0.83	0.16

Click cells to compare fundamentals

Contec Medical Account Relationship Matchups

Contec Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	12.2M	13.4M	16.3M	19.1M	27.5M	15.9M
Interest Expense	85.6K	2.4M	2.9M	19.1M	45.1M	47.4M
Selling General Administrative	10.1M	13.5M	9.4M	13.5M	16.2M	10.0M
Selling And Marketing Expenses	52.8M	61.2M	66.1M	90.2M	117.7M	63.4M
Total Revenue	387.2M	1.4B	908.7M	712.1M	734.0M	609.6M
Gross Profit	182.9M	816.2M	446.0M	338.1M	404.7M	317.7M
Other Operating Expenses	316.5M	698.9M	617.6M	589.6M	624.9M	438.6M
Operating Income	81.6M	714.6M	405.7M	219.3M	109.1M	194.0M
Ebit	86.0M	722.7M	422.0M	200.0M	109.1M	198.4M
Research Development	40.6M	48.7M	66.1M	93.3M	104.6M	54.0M
Ebitda	98.1M	736.2M	438.2M	219.0M	136.7M	214.3M
Cost Of Revenue	204.3M	585.0M	462.8M	374.0M	329.4M	291.9M
Total Operating Expenses	112.2M	113.9M	154.8M	215.5M	295.5M	310.3M
Income Before Tax	81.9M	715.5M	408.0M	219.4M	186.1M	208.0M
Total Other Income Expense Net	310.6K	835.3K	2.2M	118.6K	77.0M	80.8M
Net Income	73.8M	613.4M	352.4M	196.2M	165.8M	181.4M
Income Tax Expense	8.1M	102.1M	55.6M	23.2M	20.4M	26.7M
Tax Provision	8.1M	102.1M	55.6M	23.2M	20.4M	33.6M
Net Interest Income	19.3M	30.7M	63.2M	63.6M	33.8M	32.2M
Interest Income	20.5M	34.6M	67.1M	84.3M	81.2M	43.1M
Net Income From Continuing Ops	73.8M	613.4M	352.4M	196.2M	165.8M	226.1M
Net Income Applicable To Common Shares	73.8M	613.4M	352.4M	196.2M	225.6M	232.3M
Reconciled Depreciation	12.2M	13.4M	16.3M	19.1M	26.0M	17.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Other Information on Investing in Contec Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Contec Historical Income Statement

About Contec Income Statement Analysis

Contec Medical Income Statement Chart

Gross Profit

Contec Medical income statement Correlations

Contec Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Contec Medical income statement Accounts

Also Currently Popular

Other Information on Investing in Contec Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax
Income Tax Expense	+ 1.0	Income Before Tax
Income Tax Expense	+ 1.0	Net Income

Total Other Income Expense Net	- 0.11	Ebit
Total Other Income Expense Net	- 0.11	Operating Income
Total Other Income Expense Net	- 0.1	Ebitda
Income Tax Expense	- 0.05	Total Other Income Expense Net
Tax Provision	- 0.04	Total Other Income Expense Net
Total Other Income Expense Net	- 0.03	Income Before Tax